CPBI
Central Plains Bancshares, Inc. Common Stock
There isn't enough reported data to score CPBI yet.
JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
CPBI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
CPBI's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like CPBI.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
CPBI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $19.23 | -7.2% |
| Fair | 17x | $20.27 | -2.2% |
| Expensive | 18x | $21.33 | +2.9% |
| Current | 18x | $20.73 | — |
Historical ranges are pointers, not guarantees.
CPBI has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
CPBI Forward outlook
There aren't enough analyst estimates for CPBI to show an outlook.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
CPBI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $1.18 | +20% |
| Q1 2026 | $1.05 | +9.4% |
CPBI has the edge over JPM in the latest year-over-year earnings comparison.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
CPBI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $8.3M | +15% |
| Q1 2026 | $7.8M | +9.1% |
| Q4 2025 | $7.9M | +14% |
| Q3 2025 | $7.5M | +10% |
| Q2 2025 | $7.2M | +11% |
| Q1 2025 | $7.1M | +12% |
| Q4 2024 | $6.9M | +9% |
| Q3 2024 | $6.8M | +19% |
CPBI has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 22% | +5.2 points |
| Q1 2026 | 15% | +0.1 points |
| Q4 2025 | 19% | +1.5 points |
| Q3 2025 | 15% | -2.1 points |
| Q2 2025 | 17% | 0 points |
| Q1 2025 | 15% | -1.9 points |
| Q4 2024 | 17% | -1 points |
| Q3 2024 | 17% | -4.5 points |
CPBI's operating margin was 22% last quarter, up 5.2 points from the same quarter a year ago, near the top of its range since 2023.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over CPBI on profitability, with a higher operating margin.
CPBI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$200K | +$566K |
| Q1 2026 | $3.5M | +$4.1M |
| Q4 2025 | $2.2M | +$3.7M |
| Q3 2025 | $888K | +$1.9M |
| Q2 2025 | -$766K | -2289% |
| Q1 2025 | -$647K | -$381K |
| Q4 2024 | -$1.5M | -165% |
| Q3 2024 | -$975K | -435% |
CPBI has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
CPBI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +10.2K shares |
| 1 year | +0.5% | +17.2K shares |
| 3 years | -7.5% | -310K shares |
CPBI has 4M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $296,000 |
| Q1 2026 | $135,000 |
| Q4 2025 | $194,000 |
| Q3 2025 | $90,000 |
| Q2 2025 | $260,000 |
| Q1 2025 | $276,000 |
| Q1 2023 | — |
| Q4 2022 | — |
CPBI spent $715,000 buying back its own shares over the past year.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over CPBI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
CPBI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -5.2x | Net Cash |
| Q1 2026 | -5.0x | Net Cash |
| Q4 2025 | -4.9x | Net Cash |
| Q3 2025 | -1.7x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -5.8x | Net Cash |
| Q4 2024 | -1.3x | Net Cash |
| Q3 2024 | -2.0x | Net Cash |
CPBI has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
CPBI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.6 | Neutral |
| Stochastic | 68.0 | Neutral |
CPBI's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
CPBI PE vs Financial Services Sector
| Metric | CPBI | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 13x | 35% above |
| PE % | 63 | 41 | 22 pts above |
CPBI is trading at 18x earnings, a 35% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over CPBI on valuation relative to its sector.
CPBI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.4 | 1.9% above |
| 20 week MA | $20.5 | 1.4% above |
| 50 week MA | $18.7 | 11% above |
| 100 week MA | $17.0 | 22% above |
CPBI has stronger trend alignment. CPBI is above 4 of 4 weekly averages versus JPM above 4 of 5.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
CPBI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $9.10 | $10.2 | +12% |
| 2024 | $10.2 | $14.4 | +41% |
| 2025 | $14.4 | $16.9 | +17% |
| 2026 YTD | $16.9 | $20.7 | +22% |
CPBI has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.